Dosage escalation is designed to minimize side effects: Wegovy: Start at 0.25 mg weekly, gradually increase every 4 weeks until the maintenance dose of 2.4 mg is reached
Pratley RE, Aroda VR, Lingvay I, Ldemann J, Andreassen C, Navarria A et al (2018) Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
Always carry it with you in your carry-on bag to keep it safe and temperature-controlled
HbA1c, liver enzymes, lipid panels, and inflammatory markers may normalize weeks before weight loss becomes substantial
Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation -- a placebo-controlled study